SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

22nd-Nov-2012 11:36Source: BSE

Aurobindo Pharm - Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 22, 2012, titled "Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)."

More Announcements on:

31st-Jul-2015 10:44Source: BSE

Aurobindo Pharm - Q1 results on August 12, 2015

31st-Jul-2015 10:25Source: NSE

Aurobindo Pharma Limited

27th-Jul-2015 14:08Source: NSE

Aurobindo Pharma Limited

22nd-Jul-2015 16:24Source: NSE

Aurobindo Pharma Limited

22nd-Jul-2015 14:10Source: NSE

Aurobindo Pharma Limited

22nd-Jul-2015 13:58Source: BSE

Aurobindo Pharm - Clarifies on News item

22nd-Jul-2015 11:38Source: NSE

Aurobindo Pharma Limited

1 2 3 4 5 Next >>
Board Meeting (Aurobindo Pharm)

Meeting Date

Remark

2015-08-12

Quarterly Results

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(July 30, 2015)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.